Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Primary Care Audit of Global Risk Management (PARADIGM)

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
AstraZeneca
Information provided by (Responsible Party):
Dr. Milan Gupta, Canadian Cardiovascular Research Network
ClinicalTrials.gov Identifier:
NCT00950703
First received: July 31, 2009
Last updated: February 2, 2015
Last verified: February 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: April 2020
  Estimated Primary Completion Date: March 2020 (Final data collection date for primary outcome measure)